Published in Cold Spring Harb Perspect Biol on March 01, 2011
Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol (2012) 12.19
Macrophage biology in development, homeostasis and disease. Nature (2013) 8.28
Tumor-associated macrophages: from mechanisms to therapy. Immunity (2014) 4.69
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Differential macrophage programming in the tumor microenvironment. Trends Immunol (2012) 3.18
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models. Cancer Res (2014) 2.00
Integrated morphodynamic signalling of the mammary gland. Nat Rev Mol Cell Biol (2011) 1.50
Adaptive Immune Regulation of Mammary Postnatal Organogenesis. Dev Cell (2015) 1.48
Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories. J Cancer (2013) 1.31
Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer. Immunity (2016) 1.24
Patient-derived breast tumor xenografts facilitating personalized cancer therapy. Breast Cancer Res (2013) 1.23
89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. Bioconjug Chem (2011) 1.14
The immune system and inflammation in breast cancer. Mol Cell Endocrinol (2013) 1.12
Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis. Environ Health Perspect (2015) 1.05
Choosing a mouse model: experimental biology in context--the utility and limitations of mouse models of breast cancer. Cold Spring Harb Perspect Biol (2011) 1.03
Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. Int J Cancer (2014) 1.01
Illuminating breast cancer invasion: diverse roles for cell-cell interactions. Curr Opin Cell Biol (2014) 0.91
Regulation of cancer stem cell activities by tumor-associated macrophages. Am J Cancer Res (2012) 0.90
Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer. J Pathol Transl Med (2015) 0.88
Paracrine signaling in mammary gland development: what can we learn about intratumoral heterogeneity? Breast Cancer Res (2014) 0.88
FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis. J Exp Med (2015) 0.86
Beneficial bacteria inhibit cachexia. Oncotarget (2016) 0.86
Harnessing the immune system for the treatment of breast cancer. J Zhejiang Univ Sci B (2014) 0.85
Gut bacteria and cancer. Biochim Biophys Acta (2015) 0.84
Progress in breast cancer research. Proc Natl Acad Sci U S A (2012) 0.82
Mast cells mediate malignant pleural effusion formation. J Clin Invest (2015) 0.82
Regulation of the basement membrane by epithelia generated forces. Phys Biol (2012) 0.81
Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland. Endocrinology (2014) 0.81
Epithelial delamination and migration: lessons from Drosophila. Cell Adh Migr (2011) 0.80
Abnormal Mammary Development in 129:STAT1-Null Mice is Stroma-Dependent. PLoS One (2015) 0.79
Complement and macrophage crosstalk during process of angiogenesis in tumor progression. J Biomed Sci (2015) 0.78
Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat (2016) 0.77
Thwarting galectin-induced immunosuppression in breast cancer. Oncoimmunology (2013) 0.77
On leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol (2012) 0.77
Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective. Clin Exp Immunol (2015) 0.75
Role of Prolactin in Promotion of Immune Cell Migration into the Mammary Gland. J Mammary Gland Biol Neoplasia (2016) 0.75
In-silico insights on the prognostic potential of immune cell infiltration patterns in the breast lobular epithelium. Sci Rep (2016) 0.75
Diets high in corn oil or extra-virgin olive oil differentially modify the gene expression profile of the mammary gland and influence experimental breast cancer susceptibility. Eur J Nutr (2015) 0.75
New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment. Sci Rep (2016) 0.75
Introduction of Zinc-salt Fixation for Effective Detection of Immune Cell-related Markers by Immunohistochemistry. Toxicol Pathol (2015) 0.75
The hallmarks of cancer. Cell (2000) 113.05
New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71
Generation of a functional mammary gland from a single stem cell. Nature (2006) 18.30
Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer (2004) 14.55
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 13.79
Macrophage diversity enhances tumor progression and metastasis. Cell (2010) 13.41
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol (2000) 13.29
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol (1992) 12.96
Stromal gene expression predicts clinical outcome in breast cancer. Nat Med (2008) 10.68
Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57
Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer (2005) 10.06
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med (2001) 9.99
Distinct role of macrophages in different tumor microenvironments. Cancer Res (2006) 9.29
Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell (2005) 9.06
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell (2009) 8.54
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell (2005) 7.90
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell (2004) 7.61
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res (2004) 7.56
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell (2008) 6.78
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest (2006) 6.61
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res (2007) 6.60
Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res (2006) 6.52
Intravital imaging of cell movement in tumours. Nat Rev Cancer (2003) 6.35
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol (2006) 6.23
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev (1999) 6.10
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression. Semin Cancer Biol (2005) 6.05
Trophic macrophages in development and disease. Nat Rev Immunol (2009) 5.37
Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci U S A (2006) 4.51
Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res (2005) 4.33
A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood (2002) 4.06
Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature (2008) 3.82
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res (2007) 3.76
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood (2004) 3.59
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev (2010) 3.56
Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res (2007) 3.49
A role for hematopoietic stem cells in promoting angiogenesis. Cell (2000) 3.25
Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med (2007) 3.11
Postnatal mammary gland development requires macrophages and eosinophils. Development (2000) 3.10
Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia (2002) 2.90
Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol (2005) 2.81
An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia (2000) 2.73
A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell (2008) 2.65
Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst (1994) 2.58
Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer (2006) 2.52
Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res (2003) 2.48
Vascular endothelial growth factor mediates intracrine survival in human breast carcinoma cells through internally expressed VEGFR1/FLT1. PLoS Med (2007) 2.37
Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn (2006) 2.35
Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development (1996) 2.35
Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res (2003) 2.29
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med (2007) 2.25
Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res (2007) 2.24
Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia (2002) 2.15
Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med (2005) 2.12
Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol (2000) 2.11
Existent T-cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res (1994) 2.10
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage. Proc Natl Acad Sci U S A (2006) 2.09
The collection of the motile population of cells from a living tumor. Cancer Res (2000) 1.95
Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med (Berl) (2007) 1.90
Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res (2002) 1.90
The role of tumor stroma in the interaction between tumor and immune system. Curr Opin Immunol (2005) 1.89
Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother (2003) 1.88
Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol (2002) 1.88
Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am J Pathol (2005) 1.85
Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol (2006) 1.83
Key stages in mammary gland development: the mammary end bud as a motile organ. Breast Cancer Res (2005) 1.80
High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am J Pathol (2009) 1.80
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ (2008) 1.76
Human breast development. J Mammary Gland Biol Neoplasia (2000) 1.71
Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development (2000) 1.70
Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol (2010) 1.65
Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol (2009) 1.64
Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res (2008) 1.64
Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res (2008) 1.61
Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol (2002) 1.56
Reducing mammary cancer risk through premature stem cell senescence. Oncogene (2001) 1.54
Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci U S A (1994) 1.53
Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res (2002) 1.50
The IL-4/IL-13/Stat6 signalling pathway promotes luminal mammary epithelial cell development. Development (2007) 1.46
Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev Biol (2002) 1.45
Hematopoietic cells regulate the angiogenic switch during tumorigenesis. Blood (2004) 1.44
A delicate balance: TGF-beta and the tumor microenvironment. J Cell Biochem (2007) 1.38
Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech (2001) 1.35
The role of dendritic cell precursors in tumour vasculogenesis. Br J Cancer (2005) 1.35
Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res (1992) 1.34
Macrophages: modulators of breast cancer progression. Novartis Found Symp (2004) 1.32
STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. Neoplasia (2002) 1.32
Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia (2009) 1.31
Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim Biophys Acta (2006) 1.30
Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis. Cancer Lett (2005) 1.26
Defense of the bovine mammary gland by polymorphonuclear neutrophil leukocytes. J Mammary Gland Biol Neoplasia (2002) 1.23
Do inflammatory cells participate in mammary gland involution? J Mammary Gland Biol Neoplasia (2002) 1.20
The mammary fat pad. J Mammary Gland Biol Neoplasia (1998) 1.19
Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res (1992) 1.19
The role of CSF-1 in normal and neoplastic breast physiology. Proc Soc Exp Biol Med (1999) 1.18
Function of mucosa-associated lymphoid tissue in antibody formation. Immunol Invest (2010) 1.18
Role of the juxtamembrane domains of the transforming growth factor-alpha precursor and the beta-amyloid precursor protein in regulated ectodomain shedding. J Biol Chem (1997) 1.12
Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol (2005) 1.11
A critical role for the inflammatory response in a mouse model of preneoplastic progression. Cancer Res (2006) 1.09
Microenvironmental regulation of metastasis. Nat Rev Cancer (2008) 15.76
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 13.79
Macrophage diversity enhances tumor progression and metastasis. Cell (2010) 13.41
Distinct role of macrophages in different tumor microenvironments. Cancer Res (2006) 9.29
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature (2011) 8.62
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol (2003) 8.61
A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (2012) 8.42
Macrophage biology in development, homeostasis and disease. Nature (2013) 8.28
A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res (2004) 7.56
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res (2007) 6.60
Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res (2006) 6.52
A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood (2002) 4.06
A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One (2009) 3.86
Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res (2007) 3.49
Macrophage Wnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A (2010) 2.87
The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia (2002) 2.37
Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn (2006) 2.35
Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene (2003) 2.27
Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod (2009) 2.26
Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci U S A (2012) 2.24
Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. Immunity (2003) 2.20
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol (2011) 2.09
GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity (2012) 1.98
Absence of colony stimulation factor-1 receptor results in loss of microglia, disrupted brain development and olfactory deficits. PLoS One (2011) 1.92
Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature (2011) 1.91
Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res (2002) 1.90
Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol Oncol (2007) 1.88
High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. Am J Pathol (2009) 1.80
GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice. Cancer Res (2002) 1.77
A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis. Am J Pathol (2009) 1.70
Setup and use of a two-laser multiphoton microscope for multichannel intravital fluorescence imaging. Nat Protoc (2011) 1.67
Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors. J Immunol (2009) 1.64
Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin Cancer Res (2009) 1.58
The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12. Cancer Res (2009) 1.56
Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev Biol (2002) 1.45
The uterine NK cell population requires IL-15 but these cells are not required for pregnancy nor the resolution of a Listeria monocytogenes infection. J Immunol (2003) 1.41
Estradiol-17beta regulates mouse uterine epithelial cell proliferation through insulin-like growth factor 1 signaling. Proc Natl Acad Sci U S A (2007) 1.34
Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase-->AKT-->GSK-3beta-->cyclin D1-->pRB pathway to block uterine epithelial cell proliferation. Mol Endocrinol (2005) 1.33
Macrophages: modulators of breast cancer progression. Novartis Found Symp (2004) 1.32
Conditional deletion of the colony stimulating factor-1 receptor (c-fms proto-oncogene) in mice. Genesis (2006) 1.29
Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J Exp Med (2013) 1.27
Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors. Breast Cancer Res (2010) 1.24
Insulin cell mass is altered in Csf1op/Csf1op macrophage-deficient mice. J Leukoc Biol (2004) 1.22
Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation. Development (2010) 1.22
NRP1 acts cell autonomously in endothelium to promote tip cell function during sprouting angiogenesis. Blood (2013) 1.21
Progesterone blocks estrogen-induced DNA synthesis through the inhibition of replication licensing. Proc Natl Acad Sci U S A (2006) 1.19
Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer. Breast Cancer Res (2003) 1.10
Morphogenesis of the developing mammary gland: stage-dependent impact of adipocytes. Dev Biol (2010) 1.08
Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res (2012) 1.05
Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance. Cancer Res (2011) 1.05
Microarray analysis of uterine epithelial gene expression during the implantation window in the mouse. Endocrinology (2006) 1.04
Unexpected deposition of brown fat in mammary gland during postnatal development. Mol Endocrinol (2002) 1.04
KLF15 negatively regulates estrogen-induced epithelial cell proliferation by inhibition of DNA replication licensing. Proc Natl Acad Sci U S A (2012) 1.04
Selective depletion of eosinophils or neutrophils in mice impacts the efficiency of apoptotic cell clearance in the thymus. PLoS One (2010) 1.00
Colony-stimulating factor 1 regulation of neuroendocrine pathways that control gonadal function in mice. Endocrinology (2002) 0.98
Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders. Am J Pathol (2010) 0.97
STAT3 in epithelial cells regulates inflammation and tumor progression to malignant state in colon. Neoplasia (2013) 0.93
Th1 cytokines are essential for placental immunity to Listeria monocytogenes. Infect Immun (2005) 0.91
Progesterone regulation of the mammalian ortholog of methylcitrate dehydratase (immune response gene 1) in the uterine epithelium during implantation through the protein kinase C pathway. Mol Endocrinol (2003) 0.91
Macrophage Wnt-Calcineurin-Flt1 signaling regulates mouse wound angiogenesis and repair. Blood (2013) 0.90
Assessment of the proliferative status of epithelial cell types in the endometrium of young and menopausal transition women. Hum Reprod (2007) 0.90
Fcgamma receptor cross-linking stimulates cell proliferation of macrophages via the ERK pathway. J Biol Chem (2009) 0.88
Indoleamine 2,3-dioxygenase is regulated by IFN-gamma in the mouse placenta during Listeria monocytogenes infection. J Immunol (2003) 0.88
Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium. Hum Reprod (2009) 0.86
The CSF-1 receptor fashions the intestinal stem cell niche. Stem Cell Res (2012) 0.85
Mining the mouse transcriptome of receptive endometrium reveals distinct molecular signatures for the luminal and glandular epithelium. Endocrinology (2006) 0.84
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol (2012) 0.84
Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth. Nucl Med Biol (2005) 0.84
Colony-stimulating factor-1-dependent macrophage functions regulate the maternal decidua immune responses against Listeria monocytogenes infections during early gestation in mice. Infect Immun (2008) 0.82
The molecular basis of tamoxifen induction of mouse uterine epithelial cell proliferation. J Endocrinol (2005) 0.82
GSK-3beta mediates in the progesterone inhibition of estrogen induced cyclin D2 nuclear localization and cell proliferation in cyclin D1-/- mouse uterine epithelium. FEBS Lett (2007) 0.82
Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation. Mol Endocrinol (2003) 0.82
New tricks for metastasis-associated macrophages. Breast Cancer Res (2012) 0.81
Dynamic regulation of expression of colony-stimulating factor 1 in the reproductive tract of cattle during the estrous cycle and in pregnancy. Biol Reprod (2003) 0.77
Eotaxin Is Required for Eosinophil Homing into the Stroma of the Pubertal and Cycling Uterus. Endocrinology (2001) 0.76
The Multifaceted Role of Perivascular Macrophages in Tumors. Cancer Cell (2016) 0.75
Infection with Listeria monocytogenes as a probe for placental immunological function. Methods Mol Med (2006) 0.75